文献速递腹部技术与安全CTMR

CT灌注与MRI联合用于肝细胞癌诊断及局部区域治疗后随访

CT perfusion and MRI: A combined approach for hepatocellular carcinoma diagnosis and follow-up after locoregional treatment.
PubMed 文献 · Eur J Radiol · 2025-01-11

单中心研究纳入39例肝细胞癌监测患者,在45天内行MRI和CT肝脏灌注(CTLP),比较两者单独及联合诊断效能。CTLP敏感度75.9%、特异度95%,MRI分别为72.2%和100%(p>0.05);联合后敏感度升至85.2%(p<0.05),特异度97.5%(p>0.05)。

要点

  • CTLP与MRI对肝细胞癌诊断效能相当,联合可提高敏感度且不牺牲特异度。
  • 联合评估使5例治疗病灶和19例未治疗病灶的LI-RADS分类发生改变。
  • 联合方案可能有助于更高效地筛选适合早期个体化局部区域治疗的患者。

核心结论

  • CTLP与MRI诊断效能相当,联合可提高敏感度且不牺牲特异度,可能有助于更高效地筛选适合早期个体化局部区域治疗的患者。

研究设计与样本

  • 单中心研究,39例肝细胞癌监测患者(36例男性,31例肝硬化,16例治疗前,19例经动脉化疗栓塞后,2例消融后)在45天内行MRI和CTLP,以影像或病理为参考标准,两位阅片者用LI-RADS v2018标准评估MRI,CTLP基于平均上升斜率、达峰时间、肝动脉血流量和肝动脉分数图及既定截断值评估。

诊断标准与关键数值

  • CTLP敏感度75.9%、特异度95%,MRI敏感度72.2%、特异度100%(p>0.05);联合敏感度85.2%(p<0.05)、特异度97.5%(p>0.05)。

临床应用与阅片要点

  • 联合CTLP与MRI评估可使5例治疗病灶和19例未治疗病灶的LI-RADS分类发生改变,并影响5例的管理决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: CT liver perfusion (CTLP) has been well validated for hepatocellular carcinoma (HCC) detection, characterization, and treatment response evaluation. However, its role in HCC management algorithms remains unclear. This study aims to assess the diagnostic performance of CTLP alone or as an adjunct to MRI in patients considered for- or undergoing locoregional treatment for HCC.

MATERIAL AND METHODS: Thirty-nine patients under HCC surveillance (36 male, 31 cirrhotic, 16 pretreatment, 19 post-transarterial chemoembolization, 2 post-ablation) underwent MRI and CTLP in a single center within a 45-day interval. Two readers identified and characterized all observations on MRI using Liver Imaging Reporting and Data System (LI-RADS) v2018 criteria. CTLP assessment was based on Mean Slope of Increase (MSI), Time To Peak (TTP), Hepatic arterial Blood Flow (HaBF) and Hepatic Arterial Fraction (HAF) maps and established cut-offs. Diagnostic performance of MRI, CTLP, and their combination was evaluated for treated and untreated lesions using imaging or pathology as reference standard.

RESULTS: Of the total 33 treated and 61 untreated lesions, 13 and 41 were considered viable HCCs. CTLP demonstrated 75.9 % sensitivity and 95 % specificity compared to 72.2 % and 100 % for MRI (p > 0.05). Combining both modalities increased sensitivity to 85.2 % (p < 0.05) and maintained specificity at 97.5 % (p > 0.05). The combined approach led to an LR category change in 5 treated and 19 untreated lesions and affected management in 5 cases.

CONCLUSION: CTLP and MRI have comparable diagnostic performance for HCC. A combined approach improves sensitivity, without sacrificing specificity. This approach might enable more efficient patient selection for early and individualized loco-regional treatment.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Kalarakis G, Chryssou EG, Perisinakis K, et al. CT perfusion and MRI: A combined approach for hepatocellular carcinoma diagnosis and follow-up after locoregional treatment. Eur J Radiol. 2025. PMID: 39855148. doi:10.1016/j.ejrad.2025.111928

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。